世界のヒト化マウスモデル市場2020-2024

◆英語タイトル:Global Humanized Mouse Model Market 2020-2024
◆商品コード:IRTNTR43762
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年5月27日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではヒト化マウスモデルの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(遺伝的ヒト化マウスモデル、体細胞由来ヒト化マウスモデル)分析、エンドユーザー別(PB企業、CRO、AR機関)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・ヒト化マウスモデルの世界市場:製品別(遺伝的ヒト化マウスモデル、体細胞由来ヒト化マウスモデル)
・ヒト化マウスモデルの世界市場:エンドユーザー別(PB企業、CRO、AR機関)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Humanized Mouse Model Market 2020-2024

Technavio has been monitoring the humanized mouse model market and it is poised to grow by $ 74.72 million during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising focus on preventing the spread of pandemics and innovative applications. In addition, rising focus on preventing the spread of pandemics is anticipated to boost the growth of the market as well.

The humanized mouse model market analysis includes product segment and geographic landscapes
Technavio’s humanized mouse model market is segmented as below:
By Product
• Genetically humanized mouse model
• Cell-based humanized mouse model

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies growing adoption of personalized medicine as one of the prime reasons driving the humanized mouse model market growth during the next few years.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our humanized mouse model market covers the following areas:
• Humanized mouse model market sizing
• Humanized mouse model market forecast
• Humanized mouse model market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Champions Oncology Inc., Charles River Laboratories International Inc., genOway, Horizon Discovery Group Plc, HuMurine Technologies, ingenious targeting laboratory, JSR Corp., Taconic Biosciences Inc., The Jackson Laboratory, and TRANS GENIC Inc.. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-humanized-mouse-model-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Genetically humanized mouse model – Market size and forecast 2019-2024
o Cell-based humanized mouse model – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
o Market segments
o Comparison by end-user
o PB companies – Market size and forecast 2019-2024
o CROs – Market size and forecast 2019-2024
o AR institutions – Market size and forecast 2019-2024
o Market opportunity by end-user
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Champions Oncology Inc.
o Charles River Laboratories International Inc.
o genOway
o Horizon Discovery Group Plc
o HuMurine Technologies
o ingenious targeting laboratory
o JSR Corp.
o Taconic Biosciences Inc.
o The Jackson Laboratory
o TRANS GENIC Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: Product – Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Genetically humanized mouse model – Market size and forecast 2019-2024 ($ million)
• 25: Genetically humanized mouse model – Year-over-year growth 2019-2024 (%)
• 26: Cell-based humanized mouse model – Market size and forecast 2019-2024 ($ million)
• 27: Cell-based humanized mouse model – Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: End user – Market share 2019-2024 (%)
• 30: Comparison by End user
• 31: PB companies – Market size and forecast 2019-2024 ($ million)
• 32: PB companies – Year-over-year growth 2019-2024 (%)
• 33: CROs – Market size and forecast 2019-2024 ($ million)
• 34: CROs – Year-over-year growth 2019-2024 (%)
• 35: AR institutions – Market size and forecast 2019-2024 ($ million)
• 36: AR institutions – Year-over-year growth 2019-2024 (%)
• 37: Market opportunity by End user
• 38: Customer landscape
• 39: Market share by geography 2019-2024 (%)
• 40: Geographic comparison
• 41: North America – Market size and forecast 2019-2024 ($ million)
• 42: North America – Year-over-year growth 2019-2024 (%)
• 43: Europe – Market size and forecast 2019-2024 ($ million)
• 44: Europe – Year-over-year growth 2019-2024 (%)
• 45: Asia – Market size and forecast 2019-2024 ($ million)
• 46: Asia – Year-over-year growth 2019-2024 (%)
• 47: ROW – Market size and forecast 2019-2024 ($ million)
• 48: ROW – Year-over-year growth 2019-2024 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Champions Oncology Inc. – Overview
• 58: Champions Oncology Inc. – Business segments
• 59: Champions Oncology Inc. – Key offerings
• 60: Champions Oncology Inc. – Key customers
• 61: Champions Oncology Inc. – Segment focus
• 62: Charles River Laboratories International Inc. – Overview
• 63: Charles River Laboratories International Inc. – Product and service
• 64: Charles River Laboratories International Inc. – Key offerings
• 65: Charles River Laboratories International Inc. – Key customers
• 66: Charles River Laboratories International Inc. – Segment focus
• 67: genOway – Overview
• 68: genOway – Business segments
• 69: genOway – Key offerings
• 70: genOway – Key customers
• 71: genOway – Segment focus
• 72: Horizon Discovery Group Plc – Overview
• 73: Horizon Discovery Group Plc – Business segments
• 74: Horizon Discovery Group Plc – Key offerings
• 75: Horizon Discovery Group Plc – Key customers
• 76: Horizon Discovery Group Plc – Segment focus
• 77: HuMurine Technologies – Overview
• 78: HuMurine Technologies – Business segments
• 79: HuMurine Technologies – Key offerings
• 80: HuMurine Technologies – Key customers
• 81: HuMurine Technologies – Segment focus
• 82: ingenious targeting laboratory – Overview
• 83: ingenious targeting laboratory – Business segments
• 84: ingenious targeting laboratory – Key offerings
• 85: ingenious targeting laboratory – Key customers
• 86: ingenious targeting laboratory – Segment focus
• 87: JSR Corp. – Overview
• 88: JSR Corp. – Business segments
• 89: JSR Corp. – Key offerings
• 90: JSR Corp. – Key customers
• 91: JSR Corp. – Segment focus
• 92: Taconic Biosciences Inc. – Overview
• 93: Taconic Biosciences Inc. – Business segments
• 94: Taconic Biosciences Inc. – Key offerings
• 95: Taconic Biosciences Inc. – Key customers
• 96: Taconic Biosciences Inc. – Segment focus
• 97: The Jackson Laboratory – Overview
• 98: The Jackson Laboratory – Business segments
• 99: The Jackson Laboratory – Key offerings
• 100: The Jackson Laboratory – Key customers
• 101: The Jackson Laboratory – Segment focus
• 102: TRANS GENIC Inc. – Overview
• 103: TRANS GENIC Inc. – Business segments
• 104: TRANS GENIC Inc. – Key offerings
• 105: TRANS GENIC Inc. – Key customers
• 106: TRANS GENIC Inc. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations



【掲載企業】

Champions Oncology Inc., Charles River Laboratories International Inc., genOway, Horizon Discovery Group Plc, HuMurine Technologies, ingenious targeting laboratory, JSR Corp., Taconic Biosciences Inc., The Jackson Laboratory, TRANS GENIC Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のヒト化マウスモデル市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆